See also this year's filing and all EDGAR filings for this company.
PDF Report 0001366541_2013_Q_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001366541, Q Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,282,375 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 16,044 |
| 3 | remainder_Assets | 7,513 |
| 4 | LiabilitiesCurrent | 1,300,942 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,458,088 |
| 9 | ResearchAndDevelopmentExpense | 2,089,321 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 485,031 |
| 12 | remainder_NetIncome | 4,538 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,305,932 |
| 1 | Liabilities | 1,300,942 |
| 2 | Expenses | 3,547,409 |
| 3 | Revenues | 485,031 |
| 4 | StockholdersEquity | 4,990 |
| 5 | NetIncome | -3,057,840 |
| 6 | ComprehensiveNetIncome | -3,057,840 |
| 7 | BaseVar | 3,321,926 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.34 |
| 9 | EconomicCapitalRatio | 0.911 |
Edgar->Model Mapping
Feature Distribution
Change over Time
